ES2084587T3 - Arn virus no revertientes. - Google Patents

Arn virus no revertientes.

Info

Publication number
ES2084587T3
ES2084587T3 ES89111281T ES89111281T ES2084587T3 ES 2084587 T3 ES2084587 T3 ES 2084587T3 ES 89111281 T ES89111281 T ES 89111281T ES 89111281 T ES89111281 T ES 89111281T ES 2084587 T3 ES2084587 T3 ES 2084587T3
Authority
ES
Spain
Prior art keywords
reverting
rna viruses
vaccines
relates
rna viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89111281T
Other languages
English (en)
Inventor
Carolyn Louise Weeks-Levy
Steven Joseph Mento
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2084587T3 publication Critical patent/ES2084587T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)

Abstract

ESTE INVENTO SE REFIERE A LAS CEPAS VIRICAS DE RNA ATENUADAS, CON UN BAJO RATIO DE REVERSION Y DUPLICACION. EN PARTICULAR, ESTE INVENTO SE REFIERE A VACUNAS, Y AL USO DE TALES VACUNAS CONTENIENDO ESTAS CEPAS VIRICAS DE RNA ATENUADAS.
ES89111281T 1989-06-08 1989-06-21 Arn virus no revertientes. Expired - Lifetime ES2084587T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36361189A 1989-06-08 1989-06-08

Publications (1)

Publication Number Publication Date
ES2084587T3 true ES2084587T3 (es) 1996-05-16

Family

ID=23430924

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89111281T Expired - Lifetime ES2084587T3 (es) 1989-06-08 1989-06-21 Arn virus no revertientes.

Country Status (10)

Country Link
EP (1) EP0401421B1 (es)
JP (1) JPH0310683A (es)
AT (1) ATE132527T1 (es)
AU (1) AU630099B2 (es)
DE (1) DE68925356T2 (es)
DK (1) DK340489A (es)
ES (1) ES2084587T3 (es)
FI (1) FI893346A (es)
GR (1) GR3018670T3 (es)
IL (1) IL90743A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004003045A1 (de) 2004-01-20 2005-08-18 Man Roland Druckmaschinen Ag Formatanpassung für Produktionsdaten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800100D0 (en) * 1988-01-05 1988-02-10 Almond J W Attenuated viruses
ATE121779T1 (de) * 1988-01-11 1995-05-15 American Cyanamid Co Nichtzurückschlagende rns-viren.
GB8901094D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses

Also Published As

Publication number Publication date
DK340489D0 (da) 1989-07-10
DK340489A (da) 1990-12-09
AU3713489A (en) 1990-12-13
ATE132527T1 (de) 1996-01-15
EP0401421A2 (en) 1990-12-12
GR3018670T3 (en) 1996-04-30
EP0401421B1 (en) 1996-01-03
DE68925356D1 (de) 1996-02-15
JPH0310683A (ja) 1991-01-18
AU630099B2 (en) 1992-10-22
DE68925356T2 (de) 1996-09-05
FI893346A (fi) 1990-12-09
EP0401421A3 (en) 1991-01-30
IL90743A (en) 1996-01-19
FI893346A0 (fi) 1989-07-10
IL90743A0 (en) 1990-01-18

Similar Documents

Publication Publication Date Title
DK0386734T3 (da) Immunogene regioner på E-7-proteinet af humant papillomavirus type 16
ATE141946T1 (de) Hiv-2-virusvarianten
LU91152I2 (fr) étanique, d'anatoxine coquelucheuse, d'hémagglutinCombinaison d'anatoxine diphtérique, d'anatoxine tine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3.
PT84155A (en) Method of modifying plant viruses or their effects
ATE91902T1 (de) Hundecoronavirus-impfstoff.
DK0404625T3 (da) Oligonukleotidsekvenser til amplifikation af genomer af retrovirus af HIV-2 og SIV-typen samt deres anvendelser til in vitro-diagnose af infektioner forårsaget af disse virus
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
FI890116A0 (fi) Icke-reverterande rna-virus.
ES2113910T3 (es) Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.
ES2084587T3 (es) Arn virus no revertientes.
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
NO891355L (no) Vaksinasjon mot rabis-beslektede virus.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 401421

Country of ref document: ES